Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Yerba mate tea
DIETARY_SUPPLEMENT
2 trials
Sponsors
Instituto de Cardiologia do Rio Grande do Sul
, Instituto de Ciencia y Tecnología de Alimentos y Nutrición
Conditions
Cardiovascular Risk
Dyslipidemia
Hypercholerolemia
Inflammation
Obesity
Phase 3
Cardioprotective Effects of Green Tea Versus Maté Intake
NCT00933647
Instituto de Cardiologia do Rio Grande do Sul
Dyslipidemia, Inflammation, Obesity
Start: 2007-11-30
End: 2009-12-31
Target: 195
Updated: 2009-07-13
Unknown Phase
Study of the Effects of Yerba Mate on Cardiometabolic Health
Completed
NCT06729905
Instituto de Ciencia y Tecnología de Alimentos y Nutrición
Cardiovascular Risk, Hypercholerolemia
Start: 2012-01-10
End: 2015-05-30
Updated: 2025-05-22
Related Papers
Yerba Mate (<i>Ilex paraguariensis</i> St. Hill.) Tea May Have Cardiometabolic Beneficial Effects in Healthy and At‐Risk Subjects: A Randomized, Controlled, Blind, Crossover Trial in Nonhabitual Consumers
Molecular Nutrition & Food Research
2025-04-22
2 citations
Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial.
2019-01-19
24 citations